Buy or sell Dren Bio stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Dren Bio Stock
Dren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.
About Dren Bio Stock
Dren Bio is a biotechnology company with a portfolio of attractive projects focused on powerful protein engineering technologies for the depletion of cells, protein aggregates, and other disease-causing agents. It is a holding company business model aimed at creating value with multiple projects as stand-alone assets.
Funding History
| July 2019 | $5.1M |
|---|---|
| October 2020 | $60.0M |
| March 2022 | $62.5M |
Management
CEO and Co-Fonder
Nenad Tomasevic
Co-Founder, CFO
John Wesley
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
